SLC25A5 and kidney cancer: Survival analyses conducted on TCGA datasets of kidney cancer, that is, 533 KIRC samples and 290 KIRP samples, showed that low expression levels of SLC25A4_AAC1 and SLC25A5_AAC2 correspond to low cumulative survival probability of KIRC (see SLC25A4 and SLC25A5 panels of Figure 4) and KIRP (SLC25A4 panel of Figure 4) patients.